Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
2 Acute myeloid leukemia 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
3 Acute myeloid leukemia 💬
 4件: BRAF, FLT3, KIT, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
4 Acute myeloid leukemia 💬
 4件: BRAF, FLT3, KIT, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
5 Acute myeloid leukemia 💬
 3件: CSF1R, FLT3, KIT 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
6 Acute myeloid leukemia 💬
 3件: CSF1R, FLT3, KIT 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
7 Acute myeloid leukemia 💬
 1件: KIT 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
8 Acute myeloid leukemia 💬
 1件: KIT 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
9 Acute myeloid leukemia 💬
 1件: KIT 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
10 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
11 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
12 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
13 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
14 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
15 Acute myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
16 Acute myeloid leukemia 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
17 Acute myeloid leukemia 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
18 Acute myeloid leukemia 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
19 Adherens junction 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
20 Adherens junction 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
21 Adherens junction 💬
 2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
22 Adherens junction 💬
 2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
23 Adherens junction 💬
 2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
24 Adherens junction 💬
 2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
25 Adherens junction 💬
 1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
26 Adherens junction 💬
 1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
27 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
28 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
29 Adipocytokine signaling pathway 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
30 Adipocytokine signaling pathway 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
31 Adipocytokine signaling pathway 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
32 Adipocytokine signaling pathway 💬
 1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
33 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 Lamotrigine 💬 Lamotrigine 6件: 13, 34, 38, 113, 114, 144 💬
34 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 Lidocaine 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
35 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 Lidocaine hydrochloride 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
36 Adrenergic signaling in cardiomyocytes 💬
 1件: SCN5A 💬 Lidocaine hydrochloride monohydrate 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
37 African trypanosomiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
38 African trypanosomiasis 💬
 2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
39 African trypanosomiasis 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
40 AGE-RAGE signaling pathway in diabetic complications 💬
 5件: CCL2, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
41 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
42 AGE-RAGE signaling pathway in diabetic complications 💬
 2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
43 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
44 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
45 AGE-RAGE signaling pathway in diabetic complications 💬
 1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
46 Alanine, aspartate and glutamate metabolism 💬
 4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
47 Alanine, aspartate and glutamate metabolism 💬
 4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
48 Alanine, aspartate and glutamate metabolism 💬
 4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
49 Alcoholic liver disease 💬
 3件: IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
50 Alcoholic liver disease 💬
 2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
51 Alcoholic liver disease 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
52 Alcoholism 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
53 Alcoholism 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
54 Alcoholism 💬
 2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
55 Alcoholism 💬
 2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
56 Alcoholism 💬
 1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
57 Alcoholism 💬
 1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
58 Alcoholism 💬
 1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
59 Alcoholism 💬
 1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
60 Alcoholism 💬
 1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
61 Alcoholism 💬
 1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
62 Alcoholism 💬
 1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
63 Alcoholism 💬
 1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
64 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
65 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
66 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
67 Allograft rejection 💬
 2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
68 Allograft rejection 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
69 Allograft rejection 💬
 1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
70 Alzheimer disease 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
71 Alzheimer disease 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
72 Alzheimer disease 💬
 2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
73 Alzheimer disease 💬
 2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
74 Alzheimer disease 💬
 3件: CHRM1, CHRM3, CHRM5 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
75 Alzheimer disease 💬
 1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
76 Alzheimer disease 💬
 1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
77 Alzheimer disease 💬
 4件: IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
78 Alzheimer disease 💬
 2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
79 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
80 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
81 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
82 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
83 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
84 Alzheimer disease 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
85 Alzheimer disease 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
86 Alzheimer disease 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
87 Alzheimer disease 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
88 Alzheimer disease 💬
 1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
89 Alzheimer disease 💬
 1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
90 Alzheimer disease 💬
 1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
91 Alzheimer disease 💬
 1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
92 Alzheimer disease 💬
 1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
93 Alzheimer disease 💬
 1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
94 Alzheimer disease 💬
 1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
95 Alzheimer disease 💬
 1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
96 Alzheimer disease 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
97 Alzheimer disease 💬
 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
98 Alzheimer disease 💬
 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
99 Alzheimer disease 💬
 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
100 Alzheimer disease 💬
 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
101 Amoebiasis 💬
 4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
102 Amoebiasis 💬
 2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
103 Amoebiasis 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
104 Amphetamine addiction 💬
 1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
105 Amphetamine addiction 💬
 1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
106 AMPK signaling pathway 💬
 1件: HMGCR 💬 Lovastatin 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
107 AMPK signaling pathway 💬
 1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
108 AMPK signaling pathway 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
109 AMPK signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
110 AMPK signaling pathway 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
111 Amyotrophic lateral sclerosis 💬
 1件: ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
112 Amyotrophic lateral sclerosis 💬
 1件: ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
113 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
114 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
115 Amyotrophic lateral sclerosis 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
116 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
117 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
118 Amyotrophic lateral sclerosis 💬
 1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
119 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
120 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
121 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine 💬 Vincristine 3件: 26, 34, 331 💬
122 Amyotrophic lateral sclerosis 💬
 9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vincristine sulfate 💬 Vincristine 3件: 26, 34, 331 💬
123 Antigen processing and presentation 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
124 Antigen processing and presentation 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
125 Antigen processing and presentation 💬
 1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
126 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
127 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
128 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
129 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
130 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
131 Apelin signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
132 Apelin signaling pathway 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
133 Apelin signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
134 Apelin signaling pathway 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
135 Apelin signaling pathway 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
136 Apelin signaling pathway 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
137 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
138 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
139 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
140 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
141 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
142 Apoptosis 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
143 Apoptosis 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
144 Apoptosis 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
145 Apoptosis 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
146 Apoptosis 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
147 Apoptosis 💬
 1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
148 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
149 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
150 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
151 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
152 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
153 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
154 Arachidonic acid metabolism 💬
 2件: PTGS1, PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
155 Arachidonic acid metabolism 💬
 1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
156 Asthma 💬
 2件: IL10, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
157 Asthma 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
158 Asthma 💬
 1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
159 Autoimmune thyroid disease 💬
 1件: IL10 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
160 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
161 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
162 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
163 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
164 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
165 Autophagy - animal 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
166 Autophagy - animal 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
167 Autophagy - animal 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
168 Autophagy - animal 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
169 Autophagy - animal 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
170 Autophagy - animal 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
171 Autophagy - other 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
172 Autophagy - other 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
173 Autophagy - other 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
174 Axon guidance 💬
 1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
175 Axon guidance 💬
 1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
176 Axon guidance 💬
 1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
177 Axon guidance 💬
 1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
178 Axon guidance 💬
 1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
179 Axon guidance 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
180 Axon guidance 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
181 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
182 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
183 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
184 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
185 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
186 B cell receptor signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
187 B cell receptor signaling pathway 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
188 B cell receptor signaling pathway 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
189 Bacterial invasion of epithelial cells 💬
 1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
190 Bacterial invasion of epithelial cells 💬
 1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
191 beta-Alanine metabolism 💬
 3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
192 beta-Alanine metabolism 💬
 3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
193 beta-Alanine metabolism 💬
 3件: ABAT, E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
194 Bile secretion 💬
 1件: HMGCR 💬 Lovastatin 💬 Lovastatin 11件:  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
195 Bile secretion 💬
 1件: HMGCR 💬 Simvastatin 💬 Simvastatin 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
196 Bladder cancer 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
197 Bladder cancer 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
198 Bladder cancer 💬
 2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
199 Bladder cancer 💬
 2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
200 Bladder cancer 💬
 1件: CDK4 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
201 Bladder cancer 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
202 Bladder cancer 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
203 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
204 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
205 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
206 Bladder cancer 💬
 2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
207 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
208 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
209 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
210 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
211 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
212 Bladder cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
213 Bladder cancer 💬
 1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
214 Bladder cancer 💬
 1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
215 Breast cancer 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
216 Breast cancer 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
217 Breast cancer 💬
 4件: BRAF, FLT4, KIT, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
218 Breast cancer 💬
 4件: BRAF, FLT4, KIT, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
219 Breast cancer 💬
 2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
220 Breast cancer 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
221 Breast cancer 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
222 Breast cancer 💬
 2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
223 Breast cancer 💬
 2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
224 Breast cancer 💬
 2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
225 Breast cancer 💬
 2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
226 Breast cancer 💬
 1件: FLT4 💬 Axitinib 💬 Axitinib 1件: 34 💬
227 Breast cancer 💬
 1件: FLT4 💬 Cediranib 💬 Cediranib 1件: 34 💬
228 Breast cancer 💬
 1件: FLT4 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
229 Breast cancer 💬
 2件: FLT4, KIT 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
230 Breast cancer 💬
 2件: FLT4, KIT 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
231 Breast cancer 💬
 1件: KIT 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
232 Breast cancer 💬
 1件: KIT 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
233 Breast cancer 💬
 1件: KIT 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
234 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
235 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
236 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
237 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
238 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
239 Breast cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
240 Breast cancer 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
241 Breast cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
242 Breast cancer 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
243 Butanoate metabolism 💬
 4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
244 Butanoate metabolism 💬
 4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
245 Butanoate metabolism 💬
 4件: ABAT, ALDH5A1, E4.1.1.15, E4.1.1.15 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
246 C-type lectin receptor signaling pathway 💬
 4件: IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
247 C-type lectin receptor signaling pathway 💬
 2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
248 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
249 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
250 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
251 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
252 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
253 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
254 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
255 C-type lectin receptor signaling pathway 💬
 1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
256 C-type lectin receptor signaling pathway 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
257 C-type lectin receptor signaling pathway 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
258 C-type lectin receptor signaling pathway 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
259 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
260 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
261 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
262 Calcium signaling pathway 💬
 4件: CHRM1, CHRM2, CHRM3, CHRM5 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
263 Calcium signaling pathway 💬
 1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
264 Calcium signaling pathway 💬
 1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
265 Calcium signaling pathway 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
266 Calcium signaling pathway 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
267 Calcium signaling pathway 💬
 2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
268 Calcium signaling pathway 💬
 2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
269 Calcium signaling pathway 💬
 3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
270 Calcium signaling pathway 💬
 3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
271 Calcium signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
272 Calcium signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
273 Calcium signaling pathway 💬
 3件: FLT1, FLT4, KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
274 Calcium signaling pathway 💬
 6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
275 Calcium signaling pathway 💬
 6件: FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
276 Calcium signaling pathway 💬
 4件: FLT4, KDR, PDGFRB, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
277 Calcium signaling pathway 💬
 4件: FLT4, KDR, PDGFRB, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
278 Calcium signaling pathway 💬
 2件: KDR, MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
279 Calcium signaling pathway 💬
 2件: KDR, MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
280 Calcium signaling pathway 💬
 1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
281 Calcium signaling pathway 💬
 1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
282 Calcium signaling pathway 💬
 2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
283 Calcium signaling pathway 💬
 1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
284 Calcium signaling pathway 💬
 1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
285 cAMP signaling pathway 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
286 cAMP signaling pathway 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
287 cAMP signaling pathway 💬
 2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
288 cAMP signaling pathway 💬
 2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
289 cAMP signaling pathway 💬
 2件: CHRM1, CHRM2 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
290 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
291 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
292 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
293 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
294 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
295 cAMP signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
296 Cell cycle 💬
 1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
297 Cell cycle 💬
 1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
298 Cell cycle 💬
 1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
299 Cell cycle 💬
 2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
300 Cellular senescence 💬
 2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
301 Cellular senescence 💬
 2件: IL1A, IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
302 Cellular senescence 💬
 1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
303 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
304 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
305 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
306 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
307 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
308 Cellular senescence 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
309 Cellular senescence 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
310 Cellular senescence 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
311 Cellular senescence 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
312 Cellular senescence 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
313 Cellular senescence 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
314 Central carbon metabolism in cancer 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
315 Central carbon metabolism in cancer 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
316 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
317 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
318 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
319 Central carbon metabolism in cancer 💬
 2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
320 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
321 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRA, PDGFRB, RET 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
322 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
323 Central carbon metabolism in cancer 💬
 5件: FLT3, KIT, PDGFRB, RAF1, RET 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
324 Central carbon metabolism in cancer 💬
 2件: KIT, PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
325 Central carbon metabolism in cancer 💬
 2件: KIT, PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
326 Central carbon metabolism in cancer 💬
 3件: KIT, PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
327 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
328 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
329 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
330 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
331 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
332 Central carbon metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
333 Central carbon metabolism in cancer 💬
 1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
334 Central carbon metabolism in cancer 💬
 1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
335 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
336 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
337 Central carbon metabolism in cancer 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
338 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
339 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 Dexmedetomidine hydrochloride 💬 Dexmedetomidine 15件:  2 ,  4 ,  6 , 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
340 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
341 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
342 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
343 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
344 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
345 cGMP-PKG signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
346 cGMP-PKG signaling pathway 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
347 cGMP-PKG signaling pathway 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
348 Chagas disease 💬
 5件: CCL2, IL10, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
349 Chagas disease 💬
 2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
350 Chagas disease 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
351 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
352 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
353 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
354 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
355 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
356 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
357 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
358 Chemical carcinogenesis - DNA adducts 💬
 1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
359 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
360 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
361 Chemical carcinogenesis - reactive oxygen species 💬
 1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
362 Chemical carcinogenesis - reactive oxygen species 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
363 Chemical carcinogenesis - reactive oxygen species 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
364 Chemical carcinogenesis - reactive oxygen species 💬
 2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
365 Chemical carcinogenesis - reactive oxygen species 💬
 2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
366 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
367 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
368 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
369 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
370 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
371 Chemical carcinogenesis - reactive oxygen species 💬
 1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
372 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
373 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
374 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
375 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
376 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
377 Chemical carcinogenesis - reactive oxygen species 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
378 Chemical carcinogenesis - reactive oxygen species 💬
 1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
379 Chemical carcinogenesis - reactive oxygen species 💬
 1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
380 Chemical carcinogenesis - reactive oxygen species 💬
 1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
381 Chemical carcinogenesis - reactive oxygen species 💬
 1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
382 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
383 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
384 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
385 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
386 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
387 Chemical carcinogenesis - receptor activation 💬
 1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
388 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
389 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
390 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
391 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
392 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
393 Chemical carcinogenesis - receptor activation 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
394 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
395 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
396 Chemical carcinogenesis - receptor activation 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
397 Chemical carcinogenesis - receptor activation 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
398 Chemical carcinogenesis - receptor activation 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
399 Chemical carcinogenesis - receptor activation 💬
 1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
400 Chemical carcinogenesis - receptor activation 💬
 1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
401 Chemical carcinogenesis - receptor activation 💬
 1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
402 Chemokine signaling pathway 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
403 Chemokine signaling pathway 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
404 Chemokine signaling pathway 💬
 2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
405 Chemokine signaling pathway 💬
 2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
406 Chemokine signaling pathway 💬
 1件: CCL2 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
407 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
408 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
409 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
410 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
411 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
412 Chemokine signaling pathway 💬
 1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
413 Choline metabolism in cancer 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
414 Choline metabolism in cancer 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
415 Choline metabolism in cancer 💬
 1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
416 Choline metabolism in cancer 💬
 1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
417 Choline metabolism in cancer 💬
 1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
418 Choline metabolism in cancer 💬
 1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
419 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
420 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
421 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
422 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
423 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
424 Choline metabolism in cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
425 Choline metabolism in cancer 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
426 Choline metabolism in cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
427 Choline metabolism in cancer 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
428 Choline metabolism in cancer 💬
 1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
429 Choline metabolism in cancer 💬
 1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
430 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
431 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
432 Choline metabolism in cancer 💬
 2件: PDGFRA, PDGFRB 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
433 Choline metabolism in cancer 💬
 2件: PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
434 Choline metabolism in cancer 💬
 2件: PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
435 Cholinergic synapse 💬
 5件: CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 Glycopyrronium tosylate 💬 Glycopyrronium 2件:  6 , 34 💬
436 Cholinergic synapse 💬
 1件: CHRM3 💬 Glycopyrrolate 💬 Glycopyrronium 2件:  6 , 34 💬
437 Cholinergic synapse 💬
 1件: CHRM3 💬 Glycopyrronium 💬 Glycopyrronium 2件:  6 , 34 💬
438 Cholinergic synapse 💬
 1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
439 Cholinergic synapse 💬
 1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
440 Cholinergic synapse 💬
 1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
441 Cholinergic synapse 💬
 1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
442 Cholinergic synapse 💬
 1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
443 Cholinergic synapse 💬
 1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
444 Chronic myeloid leukemia 💬
 1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
445 Chronic myeloid leukemia 💬
 1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
446 Chronic myeloid leukemia 💬
 1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
447 Chronic myeloid leukemia 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
448 Chronic myeloid leukemia 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
449 Chronic myeloid leukemia 💬
 2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
450 Chronic myeloid leukemia 💬
 2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
451 Chronic myeloid leukemia 💬
 2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
452 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
453 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
454 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
455 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
456 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
457 Chronic myeloid leukemia 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
458 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
459 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
460 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
461 Cocaine addiction 💬
 1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
462 Cocaine addiction 💬
 1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
463 Colorectal cancer 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
464 Colorectal cancer 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
465 Colorectal cancer 💬
 2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
466 Colorectal cancer 💬
 2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
467 Colorectal cancer 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
468 Colorectal cancer 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
469 Colorectal cancer 💬
 1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
470 Colorectal cancer 💬
 1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
471 Colorectal cancer 💬
 1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
472 Colorectal cancer 💬
 1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
473 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
474 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
475 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
476 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
477 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
478 Colorectal cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
479 Colorectal cancer 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
480 Colorectal cancer 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
481 Colorectal cancer 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
482 Coronavirus disease - COVID-19 💬
 4件: CCL2, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
483 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
484 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
485 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
486 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
487 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
488 Coronavirus disease - COVID-19 💬
 1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
489 Coronavirus disease - COVID-19 💬
 2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
490 Coronavirus disease - COVID-19 💬
 1件: TLR7 💬 Imiquimod 💬 Imiquimod 2件: 34, 51 💬
491 Coronavirus disease - COVID-19 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
492 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
493 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
494 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
495 Cushing syndrome 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
496 Cushing syndrome 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
497 Cushing syndrome 💬
 1件: BRAF 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
498 Cushing syndrome 💬
 1件: BRAF 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
499 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Divalproex sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
500 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproic acid 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
501 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 Valproate sodium 💬 Valproic acid 13件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 89, 90, 127, 222, 331 💬
502 Cushing syndrome 💬
 2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
503 Cushing syndrome 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
504 Cushing syndrome 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
505 Cushing syndrome 💬
 1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
506 Cushing syndrome 💬
 1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
507 Cushing syndrome 💬
 1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
508 Cushing syndrome 💬
 1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
509 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
510 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
511 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
512 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
513 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
514 Cushing syndrome 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
515 Cysteine and methionine metabolism 💬
 3件: DNMT1, DNMT3A, DNMT3B 💬 Azacitidine 💬 Azacitidine 1件: 34 💬
516 Cytokine-cytokine receptor interaction 💬
 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
517 Cytokine-cytokine receptor interaction 💬
 1件: CSF1R 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
518 Cytokine-cytokine receptor interaction 💬
 1件: CSF1R 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
519 Cytokine-cytokine receptor interaction 💬
 1件: CSF3R 💬 Filgrastim 💬 Filgrastim 29件:  2 ,  6 , 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
520 Cytokine-cytokine receptor interaction 💬
 2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
521 Cytokine-cytokine receptor interaction 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
522 Cytosolic DNA-sensing pathway 💬
 2件: IL1B, IL6 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
523 Cytosolic DNA-sensing pathway 💬
 1件: IL6 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
524 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
525 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
526 Diabetic cardiomyopathy 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
527 Dilated cardiomyopathy 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
528 Dilated cardiomyopathy 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
529 Dilated cardiomyopathy 💬
 1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
530 Dopaminergic synapse 💬
 1件: SCN1A 💬 Lamotrigine 💬 Lamotrigine 6件: 13, 34, 38, 113, 114, 144 💬
531 Dopaminergic synapse 💬
 1件: SCN1A 💬 Lidocaine 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
532 Dopaminergic synapse 💬
 1件: SCN1A 💬 Lidocaine hydrochloride 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
533 Dopaminergic synapse 💬
 1件: SCN1A 💬 Lidocaine hydrochloride monohydrate 💬 Lidocaine 14件:  6 , 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
534 Dopaminergic synapse 💬
 1件: SLC6A3 💬 Methylphenidate hydrochloride 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
535 Dopaminergic synapse 💬
 1件: SLC6A3 💬 Methylphenidate 💬 Methylphenidate 7件:  6 , 13, 34, 84, 113, 179, 206 💬
536 Drug metabolism - other enzymes 💬
 1件: RRM1 💬 Fludarabine phosphate 💬 Fludarabine 25件: 11, 13, 19, 28, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 286, 326 💬
537 Drug metabolism - other enzymes 💬
 1件: RRM1 💬 Fludarabine 💬 Fludarabine 25件: 11, 13, 19, 28, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 286, 326 💬
538 ECM-receptor interaction 💬
 1件: SV2 💬 Levetiracetam 💬 Levetiracetam 7件:  2 ,  4 ,  6 , 13, 34, 149, 307 💬
539 Efferocytosis 💬
 1件: AXL 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
540 Efferocytosis 💬
 1件: AXL 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
541 Efferocytosis 💬
 1件: DNMT3A 💬 Azacitidine 💬 Azacitidine 1件: 34 💬
542 Efferocytosis 💬
 1件: IL10 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
543 Efferocytosis 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
544 Efferocytosis 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
545 Efferocytosis 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
546 Efferocytosis 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
547 Efferocytosis 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
548 Efferocytosis 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
549 Efferocytosis 💬
 1件: PTGS2 💬 Acetaminophen 💬 Acetaminophen 18件:  3 ,  6 , 11, 13, 19, 34, 35, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
550 Efferocytosis 💬
 1件: PTGS2 💬 Aspirin 💬 Acetylsalicylic acid 15件: 13, 22, 34, 46, 49, 51, 64, 86, 96, 97, 113, 158, 210, 231, 271 💬
551 Efferocytosis 💬
 1件: PTGS2 💬 Celecoxib 💬 Celecoxib 14件:  2 ,  3 ,  6 , 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
552 Efferocytosis 💬
 1件: PTGS2 💬 Diclofenac potassium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
553 Efferocytosis 💬
 1件: PTGS2 💬 Diclofenac sodium 💬 Diclofenac 4件: 13, 34, 46, 271 💬
554 Efferocytosis 💬
 1件: PTGS2 💬 Diclofenac 💬 Diclofenac 4件: 13, 34, 46, 271 💬
555 Efferocytosis 💬
 1件: PTGS2 💬 Diclofenac diethylamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
556 Efferocytosis 💬
 1件: PTGS2 💬 Diclofenac epolamine 💬 Diclofenac 4件: 13, 34, 46, 271 💬
557 Endocrine and other factor-regulated calcium reabsorption 💬
 1件: VDR 💬 Cholecalciferol 💬 Cholecalciferol 23件:  6 , 11, 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 65, 84, 85, 96, 97, 98, 162, 228, 271, 298, 299 💬
558 Endocytosis 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
559 Endocytosis 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
560 Endocytosis 💬
 1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
561 Endocytosis 💬
 1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
562 Endocytosis 💬
 1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
563 Endocytosis 💬
 1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
564 Endocytosis 💬
 1件: PDGFRA 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
565 Endocytosis 💬
 1件: PDGFRA 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
566 Endocytosis 💬
 1件: PDGFRA 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
567 Endocytosis 💬
 1件: PDGFRA 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
568 Endocytosis 💬
 1件: PDGFRA 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
569 Endometrial cancer 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
570 Endometrial cancer 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
571 Endometrial cancer 💬
 2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
572 Endometrial cancer 💬
 2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
573 Endometrial cancer 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
574 Endometrial cancer 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
575 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
576 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
577 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
578 Endometrial cancer 💬
 2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
579 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
580 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
581 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
582 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
583 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
584 Endometrial cancer 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
585 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
586 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
587 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
588 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
589 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
590 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
591 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: MET 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
592 Epithelial cell signaling in Helicobacter pylori infection 💬
 1件: MET 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
593 Epstein-Barr virus infection 💬
 2件: CDK4, CDK6 💬 Abemaciclib 💬 Abemaciclib 1件: 34 💬
594 Epstein-Barr virus infection 💬
 2件: IL6, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
595 Epstein-Barr virus infection 💬
 2件: IL6, TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
596 Epstein-Barr virus infection 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
597 ErbB signaling pathway 💬
 1件: ABL1 💬 Imatinib mesylate 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
598 ErbB signaling pathway 💬
 1件: ABL1 💬 Imatinib 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
599 ErbB signaling pathway 💬
 1件: ABL1 💬 Nilotinib 💬 Nilotinib 5件:  6 ,  8 , 34, 51, 86 💬
600 ErbB signaling pathway 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
601 ErbB signaling pathway 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
602 ErbB signaling pathway 💬
 2件: BRAF, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
603 ErbB signaling pathway 💬
 2件: BRAF, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
604 ErbB signaling pathway 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
605 ErbB signaling pathway 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
606 ErbB signaling pathway 💬
 2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
607 ErbB signaling pathway 💬
 2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
608 ErbB signaling pathway 💬
 3件: EGFR, ERBB2, ERBB4 💬 Neratinib 💬 Neratinib 1件: 34 💬
609 ErbB signaling pathway 💬
 3件: EGFR, ERBB2, ERBB4 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
610 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
611 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
612 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
613 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
614 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
615 ErbB signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
616 ErbB signaling pathway 💬
 1件: MTOR 💬 Everolimus 💬 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
617 ErbB signaling pathway 💬
 1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
618 ErbB signaling pathway 💬
 1件: MTOR 💬 Temsirolimus 💬 Temsirolimus 4件: 13, 34, 89, 331 💬
619 Estrogen signaling pathway 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
620 Estrogen signaling pathway 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
621 Estrogen signaling pathway 💬
 1件: EGFR 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
622 Estrogen signaling pathway 💬
 1件: EGFR 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
623 Estrogen signaling pathway 💬
 1件: EGFR 💬 Neratinib 💬 Neratinib 1件: 34 💬
624 Estrogen signaling pathway 💬
 1件: EGFR 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
625 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
626 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
627 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
628 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
629 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
630 Estrogen signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
631 Estrogen signaling pathway 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
632 Estrogen signaling pathway 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
633 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
634 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
635 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
636 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
637 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
638 Fc epsilon RI signaling pathway 💬
 2件: MAP2K1, MAP2K2 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
639 Fc epsilon RI signaling pathway 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
640 Fc epsilon RI signaling pathway 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
641 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
642 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
643 Fc epsilon RI signaling pathway 💬
 1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
644 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 Binimetinib 💬 Binimetinib 1件: 34 💬
645 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 Mirdametinib 💬 Mirdametinib 4件: 34, 278, 279, 280 💬
646 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 Selumetinib 💬 Selumetinib 1件: 34 💬
647 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 Selumetinib sulfate 💬 Selumetinib 1件: 34 💬
648 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 Trametinib 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
649 Fc gamma R-mediated phagocytosis 💬
 1件: MAP2K1 💬 Trametinib dimethyl sulfoxide 💬 Trametinib 6件:  2 , 34, 58, 195, 279, 280 💬
650 Fc gamma R-mediated phagocytosis 💬
 1件: RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
651 Fc gamma R-mediated phagocytosis 💬
 1件: RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
652 Fluid shear stress and atherosclerosis 💬
 4件: CCL2, IL1A, IL1B, TNF 💬 Pirfenidone 💬 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
653 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 Axitinib 💬 Axitinib 1件: 34 💬
654 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 Cabozantinib 💬 Cabozantinib 1件: 34 💬
655 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 Cabozantinib s-malate 💬 Cabozantinib 1件: 34 💬
656 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 Cediranib 💬 Cediranib 1件: 34 💬
657 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 Cediranib maleate 💬 Cediranib 1件: 34 💬
658 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
659 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
660 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 Sunitinib malate 💬 Sunitinib 2件: 28, 34 💬
661 Fluid shear stress and atherosclerosis 💬
 1件: KDR 💬 Sunitinib 💬 Sunitinib 2件: 28, 34 💬
662 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 Lenalidomide 💬 Lenalidomide 8件: 16, 26, 28, 34, 49, 284, 300, 331 💬
663 Fluid shear stress and atherosclerosis 💬
 1件: TNF 💬 Pomalidomide 💬 Pomalidomide 6件: 28, 34, 51, 85, 227, 331 💬
664 Fluid shear stress and atherosclerosis 💬
 1件: VEGFA 💬 Bevacizumab 💬 Bevacizumab 8件: 13, 34, 85, 87, 89, 227, 280, 331 💬
665 Fluid shear stress and atherosclerosis 💬
 1件: VEGFA 💬 Ranibizumab 💬 Ranibizumab 4件: 34, 166, 227, 301 💬
666 Focal adhesion 💬
 1件: BRAF 💬 Dabrafenib 💬 Dabrafenib 1件: 34 💬
667 Focal adhesion 💬
 1件: BRAF 💬 Dabrafenib mesylate 💬 Dabrafenib 1件: 34 💬
668 Focal adhesion 💬
 5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 Sorafenib tosylate 💬 Sorafenib 2件: 34, 86 💬
669 Focal adhesion 💬
 5件: BRAF, FLT4, KDR, PDGFRB, RAF1 💬 Sorafenib 💬 Sorafenib 2件: 34, 86 💬
670 Focal adhesion 💬
 1件: EGFR 💬 Cetuximab 💬 Cetuximab 5件: 34, 51, 86, 89, 331 💬
671 Focal adhesion 💬
 1件: EGFR 💬 Icotinib 💬 Icotinib 1件: 34 💬
672 Focal adhesion 💬
 2件: EGFR, ERBB2 💬 Lapatinib ditosylate 💬 Lapatinib 3件: 34, 74, 75 💬
673 Focal adhesion 💬
 2件: EGFR, ERBB2 💬 Lapatinib 💬 Lapatinib 3件: 34, 74, 75 💬
674 Focal adhesion 💬
 2件: EGFR, ERBB2 💬 Neratinib 💬 Neratinib 1件: 34 💬
675 Focal adhesion 💬
 2件: EGFR, ERBB2 💬 Neratinib maleate 💬 Neratinib 1件: 34 💬
676 Focal adhesion 💬
 3件: FLT1, FLT4, KDR 💬